MORF(Delisted)
Morphic HoldingยทNASDAQ
--
--(--)
MORF Profile
Morphic Holding, Inc.
A biopharmaceutical company that develops a new generation of oral integrin therapies for the treatment of serious chronic diseases
35 Gatehouse Drive, A2, Waltham, Massachusetts 02451
--
Morphic Holding, Inc., was incorporated in August 2014 under the laws of the State of Delaware. They are a biopharmaceutical company applying their proprietary insights to integrins to discover and develop potentially first-in-class oral small molecule integrin therapies. Integrins are a target class of injectable blockbuster drugs with multiple approvals for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. Using their unique understanding of integrin structure and biology, they created the Morphic Integrin Technology Platform, or MInT Platform, to develop new product candidates designed to achieve the potency, high selectivity and drug properties required for oral administration.
